UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
American psychiatrists' opinions about classic hallucinogens and their potential therapeutic applications: A 7-year follow-up survey
Our data reveal a striking positive shift in attitudes toward the therapeutic potential of hallucinogens among American psychiatrists since 2016, with a majority of responding psychiatrists planning to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.
“We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions
Additional research and a clear presentation of this research are needed before the clinical use of psychedelics can be supported.
The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists
we suggest there is scope to develop up-to-date education about psychedelics for psychiatrists.
Naturalistic psychedelic use: A world apart from clinical care
Among 1,435 participants, 72.5% never discussed psychedelic use with their primary care provider (PCP).
Counselors’ attitudes (in USA) toward psychedelics and their use in therapy
Most counselors see potential in PAT and the need for additional research.
Most addiction specialists support legalized therapeutic psychedelics
The majority of US addiction specialists, including psychiatrists, believe psychedelics are promising for the treatment of substance use disorders.
The readiness of psychiatrists to implement psychedelic-assisted psychotherapy
NHS psychiatrists are positive about the potential for psychedelic-assisted therapy to advance psychiatric practise.
Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy: A preliminary investigation
Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy
YouGov results - Is the UK ready to reschedule psilocybin?
UK survey on attitudes to psilocybin